NCT04555733View on ClinicalTrials.gov

A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

January 13, 2021

Study Completion Date

January 13, 2021

Conditions
Healthy Volunteer
Interventions
DRUG

Lemborexant

Lemborexant oral tablets.

Trial Locations (1)

Unknown

Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT04555733 - A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants | Biotech Hunter | Biotech Hunter